Skip to content

Two-sample FIT-screening: a 4th screening round

Fourth round of two-sample fecal immunochemical test screening for colorectal cancer in the Netherlands

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20828
Enrollment
3197
Registered
2016-03-11
Start date
2015-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer, screening, darmkanker

Interventions

People will receive two identical FITs (OC-sensor, Eiken Japan) to sample from two consecutive bowel movements.

Sponsors

Erasmus Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Average risk persons aged 50-75 years old in the Rotterdam-Rijnmond region. We will invite all persons from the dynamic cohort of approximately 3200 persons that were invited in the previous rounds and were originally recruited by random selection in the city population database (Gemeentelijke Basis Administratie, GBA).

Exclusion criteria

Exclusion criteria: Exclusion criteria for colonoscopy are: complete colonoscopy or CT-colonography performed within the last 2 years; severe co-morbidity (ASA IV/V); terminal disease (life-expectancy < 5 years); inability or refusal to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Participation, positivity rate, diagnostic yield of two-sample FIT screening.

Secondary

MeasureTime frame
Participation-rate and diagnostic yield of a 4th round of biennial two-sample FIT-screening compared to previous rounds. Impact of repeated biennial two-sample FIT-screening on participation-rates (per round, in consecutive rounds and per program), as well as the yield and occurrence of interval cancers in participants and non-participants of repeated rounds. Comparison of outcomes with paralell one-sample FIT screening cohort.

Contacts

Public ContactM.C.W. Spaander

Erasmus Medical Center Rotterdam

v.spaander@erasmusmc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)